RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Thyroid Gland Disorders - Pipeline Review, Q2 2011
May 2011 - 23 pages - $500
Growth Disorders - Pipeline Review, H2 2011
Sep 2011 - 66 pages - $500
Medullary Thyroid Cancer - Pipeline Review, Q1 2011
Jan 2011 - 26 pages - $500
Lixte Biotechnology Holdings, Inc. (LIXT) - Strategic SWOT Analysis Review
May 2011 - 20 pages - $125
Companion Diagnostics Partnering Terms and Agreements
Apr 2011 - 250 pages - $2,695
Merck KGaA Pipeline, Products, Performance, Potential
Jun 2009 - 144 pages - $1,040
Thyroid Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Apr 2011 - 78 pages - $2,000
Quest Diagnostics Incorporated: SWOT Analysis & Company Profile
Sep 2010 - 25 pages - $99
Lixte Biotechnology Holdings, Inc. (LIXT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Mar 2011 - 17 pages - $250
Lixte Biotechnology Holdings, Inc. - Strategic SWOT Analysis Review
Dec 2010 - 18 pages - $125
More Related Market Research Reports >>>

Your selection

Industry sector
Biotechnology del
Human diagnostics del
Therapeutic target
Endocrinology del
Thyroid disorders del
Year
2011 del

Browse By

Therapeutic target
Hyperparathyroidism
Hyperthyroidism
Hypothyroidism

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us